Eosinophilic gastrointestinal diseases (EGIDs) are serious, chronic, inflammatory digestive disorders characterized by excessive infiltration of eosinophils into gastrointestinal (GI) tissues. Lengthy diagnostic delays are common and often result in disease progression and missed treatment opportunities. In this live CME event, 3 experts will discuss the pathophysiology, diagnosis, and treatment of EGIDs below the esophagus. They will present the latest evidence for the efficacy of specialized diets and promising emerging pharmacologic agents that may soon alter the course of these diseases for many patients.
The goal of this activity is to improve clinicians' understanding of EGIDs pathology and novel treatment targets, as well as key diagnostic criteria in order to facilitate more timely diagnosis.
Upon completion of this activity, participants will: Have increased knowledge regarding the [LIST] [ITEM]Clinical data on novel and emerging treatments for EGIDs [/LIST]Have greater competence related to [LIST] [ITEM] Facilitating a timely diagnosis of EGIDs [ITEM]Selecting treatment options for patients with EGIDs[/LIST]Demonstrate greater confidence in their ability to [LIST] [ITEM]Incorporate new and emerging treatments for EGIDs into practice[/LIST]
In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. [JALOGO] [MEDSCAPE]
[bold]For Physicians[/bold] Medscape, LLC designates this live activity for a maximum of 1.0 [italic]AMA PRA Category 1 Credits™[/italic]. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Mandalay Bay Resort & Casino
3950 South Las Vegas Boulevard Oceanside Ballroom Section D (Level 2, South Convention Center)
Las Vegas, Nevada, 89119